treat people in very early stage covid, they were so good that the folks who were monitoring the trial said, you know what, let s stop it so that these folks, so pfizer can go to the fda and try to get authorization. that s how good the results are. that doesn t happen very hoofte. but it happened with this antiviral and the antiviral that merck applied for emergency use authorization for. it may be in the future we could have two antivirals to treat covid, which would be amazing, especially since these are pills. let s look at the results from this pfizer trial. what they found was they had 774 patients. very early stage covid patients, divided them in half. the half that receive the placebo over the next four weeks or so, 27 of them ended up in the hospital, and seven of those people died. you got a placebo, 27 in the hospital, seven died. when they got the pill, they got the antiviral pill, three ended up in the hospital and zero